
Ochre Bio
@OchreBio
Followers
785
Following
201
Media
290
Statuses
610
Breaking the silence of a top ten global killer: Chronic liver disease.
Oxford, UK
Joined August 2020
🚀 Announcing our new multi-year data license agreement with @GSK to investigate the drivers of #liverdisease! . Read the announcement ➡️ .
0
8
33
4.5M US adults live with chronic liver disease, & transplant demand far outpaces donors. In a recent @MayoClinic video, Dr. Bashar Aqel talks about the anxious waits for life-saving surgery that many patients face while their conditions deteriorate. 🎥
0
0
0
Liver therapies are undergoing their most significant disruption in decades. In @thetimes, @Quin_Wills discusses how metabolic drugs like Wegovy & Mounjaro are moving us from symptom control to targeted therapies. Read the full article:
0
0
0
RT @healthtechworld: Oxford-based @OchreBio, a biotechnology company developing RNA therapeutics for chronic liver disease, has appointed D….
0
1
0
AI is reshaping how we diagnose and treat disease. In @DailyMailUK, @LaraLewington explores this shift, featuring our work using machine learning and human liver data to develop RNA therapies for late-stage disease. Article 👉
0
1
2
🎉 Huge congratulations to the Ochre team who completed Sunday’s @raceforlife for @CR_UK!. Support the team here👉
1
0
0
Announcing Dr. @QuinWills as the new CEO of Ochre Bio 👏 . As founder & former CSO, Quin has shaped our RNA therapy strategy from day one. He now leads Ochre into it's next phase: progressing new drug candidates toward the clinic. 🔗
0
0
2
We've been included in @BloombergUK & @Founders_Forum's 25 European companies to watch in 2025!. Grateful to be highlighted for our work in advanced liver disease, alongside other innovative companies in genAI, auto vehicles, space & biotech.🚀. Full list➡️
0
0
0
That was the thread running through our Founder @QuinWills' talk at @sxswlndn – on a stage next to a perfused human liver and some big questions about how we treat liver disease.
1
0
0
🚨 @Quin_Wills is on stage today at #SXSWLondon. 🕒 14:30–14:55 | Truman Brewery Stage 1. He’ll share how we combine machine learning with human-first lab models to move beyond animal testing & improve drug discovery for liver disease. Dont miss out 👉
0
1
2
📊 Weight-loss medications are showing significant benefits, particularly for liver health. In @thetimes, our Founder & CSO @QuinWills explores what this means for liver disease & cirrhosis, & why these first-gen therapies are only part of the story. 🔗
0
0
0